Cargando…

The Potential Roles of Post-Translational Modifications of PPARγ in Treating Diabetes

The number of patients with type 2 diabetes mellitus (T2DM), which is mainly characterized by insulin resistance and insulin secretion deficiency, has been soaring in recent years. Accompanied by many other metabolic syndromes, such as cardiovascular diseases, T2DM represents a big challenge to publ...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ji, Xiaohui, Zhang, Wenqian, Yin, Liqin, Shi, Zunhan, Luan, Jinwen, Chen, Linshan, Liu, Longhua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9775095/ https://www.ncbi.nlm.nih.gov/pubmed/36551260 http://dx.doi.org/10.3390/biom12121832

Ejemplares similares

The Role of Peroxisome Proliferator-Activated Receptor Gamma and Atherosclerosis: Post-translational Modification and Selective Modulators
por: Yin, Liqin, et al.
Publicado: (2022)

Exercise Promotes Bone Marrow Microenvironment by Inhibiting Adipsin in Diet-Induced Male Obese Mice
por: Shi, Zunhan, et al.
Publicado: (2022)

PPARγ in Atherosclerotic Endothelial Dysfunction: Regulatory Compounds and PTMs
por: Luan, Jinwen, et al.
Publicado: (2023)

Functional Regulation of PPARs through Post-Translational Modifications
por: Brunmeir, Reinhard, et al.
Publicado: (2018)

PPARγ Deacetylation Confers the Antiatherogenic Effect and Improves Endothelial Function in Diabetes Treatment
por: Liu, Longhua, et al.
Publicado: (2020)

The therapeutic potential of inhibiting PPARγ phosphorylation to treat type 2 diabetes
por: Frkic, Rebecca L., et al.
Publicado: (2021)

PPARγ and Apoptosis in Cancer
por: Elrod, Heath A., et al.
Publicado: (2008)

PPARγ and PPARδ as Modulators of Neoplasia and Cell Fate
por: Glazer, Robert I., et al.
Publicado: (2008)

Modifications of Human Subcutaneous ADMSC after PPARγ Activation and Cold Exposition
por: Vargas, Diana, et al.
Publicado: (2015)

Regulation of Translational Efficiency by Disparate 5′ UTRs of PPARγ Splice Variants
por: McClelland, Shawn, et al.
Publicado: (2009)

PPARγ in Neuroblastoma
por: Peri, Alessandro, et al.
Publicado: (2008)

Obesity-linked phosphorylation of PPARγ by cdk5 is a direct target of the anti-diabetic PPARγ ligands
por: Choi, Jang Hyun, et al.
Publicado: (2010)

PPARγ Acetylation Orchestrates Adipose Plasticity and Metabolic Rhythms
por: He, Ying, et al.
Publicado: (2022)

Re-highlighting the action of PPARγ in treating metabolic diseases
por: Choi, Sung Hee, et al.
Publicado: (2018)

Investigation of post-translational modifications in type 2 diabetes
por: Chatterjee, Bhaswati, et al.
Publicado: (2018)

Emerging PPARγ-Independent Role of PPARγ Ligands in Lung Diseases
por: Kulkarni, Ajit A., et al.
Publicado: (2012)

Post translational modification of Parkin
por: Chakraborty, Joy, et al.
Publicado: (2017)

Post‐translational modifications of the cardiac proteome in diabetes and heart failure
por: Wende, Adam R.
Publicado: (2015)

PPARγ, neuroinflammation, and disease
por: Mrak, Robert E, et al.
Publicado: (2004)

Nutraceuticals as Ligands of PPARγ
por: Penumetcha, Meera, et al.
Publicado: (2012)

PPARγ and Cognitive Performance
por: d’Angelo, Michele, et al.
Publicado: (2019)

New Insights into the PPARγ Agonists for the Treatment of Diabetic Nephropathy
por: Jia, Zhanjun, et al.
Publicado: (2014)

Control of protein stability by post-translational modifications
por: Lee, Ji Min, et al.
Publicado: (2023)

Phosphorylation of PPARγ Affects the Collective Motions of the PPARγ-RXRα-DNA Complex
por: Lemkul, Justin A., et al.
Publicado: (2015)

Ups and downs: The PPARγ/p-PPARγ seesaw of follistatin-like 1 and integrin receptor signaling in adipogenesis
por: Fang, Dongliang, et al.
Publicado: (2021)

Non-proteolytic ubiquitin modification of PPARγ by Smurf1 protects the liver from steatosis
por: Zhu, Kun, et al.
Publicado: (2018)

The Roles of Post-Translational Modifications on mTOR Signaling
por: Yin, Shasha, et al.
Publicado: (2021)

An Upstream Open Reading Frame Represses Translation of Chicken PPARγ Transcript Variant 1
por: Chu, Yankai, et al.
Publicado: (2020)

Comparative Gene Expression Profiles Induced by PPARγ and PPARα/γ Agonists in Human Hepatocytes
por: Rogue, Alexandra, et al.
Publicado: (2011)

Prenatal Exposure to Benzophenone-3 Impairs Autophagy, Disrupts RXRs/PPARγ Signaling, and Alters Epigenetic and Post-Translational Statuses in Brain Neurons
por: Wnuk, Agnieszka, et al.
Publicado: (2018)

Scaffold-Based Pan-Agonist Design for the PPARα, PPARβ and PPARγ Receptors
por: Zhang, Li-Song, et al.
Publicado: (2012)

Post-Translational Modifications of TRP Channels
por: Voolstra, Olaf, et al.
Publicado: (2014)

Absolute quantitation of post-translational modifications
por: Chaube, Ruchi
Publicado: (2014)

Post-Translational Modifications of Exosomal Proteins
por: Moreno-Gonzalo, Olga, et al.
Publicado: (2014)

Orchestrating the proteome with post-translational modifications
por: Spoel, Steven H
Publicado: (2018)

Global Post-Translational Modification Discovery
por: Li, Qiyao, et al.
Publicado: (2016)

Post-Translational Modifications of Extracellular Proteasome
por: Tsimokha, Anna S., et al.
Publicado: (2020)

Dynamic post‐translational modifications in obesity
por: Yang, Hong, et al.
Publicado: (2019)

Post-translational protein modifications in schizophrenia
por: Mueller, Toni M., et al.
Publicado: (2020)

Post-translational Modifications of the Protein Termini
por: Chen, Li, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_i9ee66l9er733b99urh16399na